Table 1.
Characteristics of included studies.
| Author | Published year | Country | Chinese Medicinal formulas | Model group | Western medicine | Sample size | Doses | Duration |
|---|---|---|---|---|---|---|---|---|
| CMF/Model/WM | ||||||||
| Zhou et al. (32) | 2020 | China | Xiaokeyinshuiextract combination | DKD | Metformin | 7/7/7 | 0.5 g/kg | 60 days |
| Fang et al. (35) | 2012 | China | Fufang xue shuan tong capsules | DKD | captopril | 8/7/7 | 1.8 g/kg | 3 months |
| Li et al. (36) | 2021 | China | Huayu Tongluo Recipe | DKD | irbesartan | 10/9/9 | 4.59 g/kg | 6 weeks |
| Han et al. (37) | 2017 | China | Huangqi decoction | DKD | rosiglitazone | 8/8/8 | 0.45 g/kg | 8 weeks |
| Xu et al. (31) | 2017 | China | Liuwei Dihuang | DKD | valsartan | 22/23 /23 | 6.7 g/kg | 8 weeks |
| Zhenwu decoction | 22/23/23 | 3 g/kg | 8 weeks | |||||
| Chen et al. (38) | 2016 | China | Shuangdan Oral Liquid | DKD | Insulin | 12/12/12 | 5 mg/kg | 8 weeks |
| Zhang et al. (33) | 2021 | China | Yi Shen Pai Du Formula | DKD |
|
10/10 | 2.88 g/kg | 8 weeks |
| Zhu et al. (34) | 2021 | China | Compound centella formula | DKD | losartan | 7/7/7 | 5.4 mg/1kg | 80 days |